14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Session X : Cell death in cancer Poster X, 36<br />

Antigens <strong>and</strong> cytokine gene in antitumoral vaccines: the importance of the temporal<br />

delivery sequence in the antitumor signals<br />

Maria Jose Herrero, Rafael Botella, Francisco Dasi, Rosa Algas, Maria Sanchez,<br />

Salvador F. Aliño.<br />

Laboratory of Gene Therapy, Department of Pharmacology, Faculty of Medicine,<br />

University of Valencia. Avda Blasco Ibáñez, 15. 46010 Valencia-España. E-mail:<br />

mariajoseherrero@ono.com<br />

Different studies against cancer in the last years, including clinical trials, have shown that a<br />

correct activation of the immune system can lead to tumor rejection but also, on the other<br />

h<strong>and</strong>, an incorrect signalling results in no positive effects or even anergy. How the different<br />

signals must be given to the immune system in order to get one or the other response is not<br />

clear yet. Knowing that the genetic cell vaccines with cytokine genes as gm-csf (granulocyte<br />

<strong>and</strong> macrophage colony stimulating factor) are the best to mediate efficient antitumoral<br />

responses, we have worked assuming that both signals, GM-CSF <strong>and</strong> tumor antigens, are<br />

crucial. In order to study which is the ideal temporal sequence for their administration we<br />

have worked in a murine model of antimelanoma vaccine, with B16 cells <strong>and</strong> C57/BL6 mice,<br />

using tumor membrane protein antigens (TMP) or whole tumor cells in combination with gmcsf<br />

transfer before or after the antigen delivery. B16 cells were transfected using PEI<br />

(polyethyleneimine) polyplexes (0.02 mg/ml). Tisular transfection in TMP experiments was<br />

performed by sc. injection of 0.01 or<br />

0.05 mg m-gmcsf in 0.5 ml saline solution. Our results show that: 1) when gmcsf tisular<br />

transfection is performed before TMP delivery, a good dose-dependent correlation in tumor<br />

volume decrease is observed, but with a limit effect; in contrast, when higher doses of antigen<br />

were administered before DNA transfection, more antitumor efficacy was obtained. 2) A<br />

similar behavi<strong>our</strong>, but with stronger positive results, was observed employing whole tumor<br />

cells as antigens. Thus, an inefficient or efficient (total survival of treated mice) antitumoral<br />

response was observed when DNA was administered before or after the cell vaccine,<br />

respectively. We conclude that optimal antitumoral response can be obtained when a high<br />

antigen signal is given before (or simultaneously) to GMCSF production, while the inversion<br />

of the signals could result in the non desired inhibition or anergy of the immune response.<br />

- 369 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!